Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/61670
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDeane, A.en
dc.contributor.authorNguyen, Q.en
dc.contributor.authorStevens, J.en
dc.contributor.authorFraser, R.en
dc.contributor.authorHolloway, R.en
dc.contributor.authorBesanko, L.en
dc.contributor.authorBurgstad, C.en
dc.contributor.authorJones, K.en
dc.contributor.authorChapman, M.en
dc.contributor.authorRayner, C.en
dc.contributor.authorHorowitz, M.en
dc.date.issued2010en
dc.identifier.citationJournal of Clinical Endocrinology and Metabolism, 2010; 95(1):215-221en
dc.identifier.issn0021-972Xen
dc.identifier.issn0021-972Xen
dc.identifier.urihttp://hdl.handle.net/2440/61670-
dc.description.abstractIntroduction: The role of glucagon-like peptide-1 (GLP-1) in the regulation of gastric emptying is uncertain. The aim of this study was to determine the effects of endogenous GLP-1 on gastric emptying, glucose absorption, and glycemia in health. Methods: Ten healthy fasted subjects (eight males, two females; 48 ± 7 yr) received the specific GLP-1 antagonist, exendin(9-39) amide [ex(9-39)NH2] (300 pmol/kg · min iv), or placebo, between –30 and 180 min in a randomized, double-blind, crossover fashion. At 0 min, a mashed potato meal (~2600 kJ) containing 3 g 3-ortho-methyl-D-glucose (3-OMG) and labeled with 20 MBq 99mTechnetium-sulphur colloid was eaten. Gastric emptying, including the time taken for 50% of the meal to empty from the stomach (T50), blood glucose, plasma 3-OMG, and plasma insulin were measured. Results: Ex(9-39)NH2 accelerated gastric emptying [T50 ex(9-39)NH2, 68 ± 8 min, vs. placebo, 83 ± 7 min; P < 0.001] and increased the overall glycemic response to the meal [area under the curve (0-180 min) ex(9-39)NH2, 1540 ± 106 mmol/liter · min, vs. placebo, 1388 ± 90 mmol/liter · min; P < 0.02]. At 60 min, ex(9-39)NH2 increased the rise in glycemia [ex(9-39)NH2, 9.9 ± 0.5 mmol/liter, vs. placebo, 8.4 ± 0.5 mmol/liter; P < 0.01], plasma 3-OMG [ex(9-39)NH2, 0.25 ± 0.01 mmol/liter, vs. placebo, 0.21 ± 0.01 mmol/liter; P < 0.05], and plasma insulin [ex(9-39)NH2, 82 ± 13 mU/liter, vs. placebo, 59 ± 9 mU/liter; P < 0.05] concentrations. There was a close within-subject correlation between glycemia and gastric emptying [e.g. at 60 min, the increment in blood glucose and gastric emptying (T50); r = –0.89; P < 0.001]. Conclusion: GLP-1 plays a physiological role to slow gastric emptying in health, which impacts on glucose absorption and, hence, postprandial glycemia.en
dc.description.statementofresponsibilityAdam M. Deane, Nam Q. Nguyen, Julie E. Stevens, Robert J. L. Fraser, Richard H. Holloway, Laura K. Besanko, Carly Burgstad, Karen L. Jones, Marianne J. Chapman, Chris K. Rayner and Michael Horowitzen
dc.language.isoenen
dc.publisherEndocrine Societyen
dc.rightsCopyright © 2010 by The Endocrine Societyen
dc.subjectHumans; Hyperglycemia; Hormone Antagonists; Insulin; Blood Glucose; Peptide Fragments; Guanosine; Placebos; Cross-Over Studies; Double-Blind Method; Gastric Emptying; Adult; Middle Aged; Health; Female; Male; Glucagon-Like Peptide 1en
dc.titleEndogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemiaen
dc.typeJournal articleen
dc.identifier.rmid0020100087en
dc.identifier.doi10.1210/jc.2009-1503en
dc.identifier.pubid33821-
pubs.library.collectionAnaesthesia and Intensive Care publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidDeane, A. [0000-0002-7620-5577]en
dc.identifier.orcidJones, K. [0000-0002-1155-5816]en
dc.identifier.orcidChapman, M. [0000-0003-0710-3283]en
dc.identifier.orcidRayner, C. [0000-0002-5527-256X]en
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]en
Appears in Collections:Anaesthesia and Intensive Care publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.